Status:
WITHDRAWN
Noninvasive Predictors of Transplant Vasculopathy
Lead Sponsor:
University of Minnesota
Conditions:
Cardiac Allograft Vasculopathy
Eligibility:
All Genders
18+ years
Brief Summary
Post transplant vasculopathy is a major negative outcome in heart transplantation. Current methods of detection are highly invasive and pose a risk to transplant recipients. Noninvasive markers of end...
Detailed Description
Cardiac transplantation has become the established treatment of choice for eligible patients with end-stage heart failure. Cardiac allograft vasculopathy (CAV) is a major and potentially preventable ...
Eligibility Criteria
Inclusion
- Provide informed consent
- Age 18 years and greater
- Cardiac transplant recipients who have been transplanted for more than one year
Exclusion
- Chronic kidney disease stage 4 defined as GFR \<30
- Acute Rejection grade 3A or greater
- Active Infection
- Re-transplant
- Multiorgan Transplant
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01424917
Start Date
March 1 2008
End Date
December 1 2013
Last Update
January 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiology Division, University of Minnesota
Minneapolis, Minnesota, United States, 55455